Harvard Bioscience (HBIO) Interest Expenses (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Interest Expenses data on file, last reported at $1.4 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 52.29% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 52.29% increase from a year earlier, with the FY2025 full-year figure at $19.9 million, up 11.84% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.4 million, up from $1.2 million in the prior quarter.
• Over the last five years, Interest Expenses for HBIO reached as high as $10.4 million in Q3 2022 and fell as low as -$1.9 million in Q4 2023.
• Historically, Interest Expenses has averaged $1.6 million across 5 years, with a median of $1.3 million in 2023.
• Across the five-year window, Interest Expenses sank 424.15% in 2023 and surged 174.51% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $588000.0 in 2022, then sank by 424.15% to -$1.9 million in 2023, then rose by 17.68% to -$1.6 million in 2024, then jumped by 174.51% to $1.2 million in 2025, then rose by 22.33% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $1.4 million in Q1 2026, $1.2 million in Q4 2025, and $949000.0 in Q3 2025.